This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/domain/vavai/projekt/
n8http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n7http://linked.opendata.cz/ontology/domain/vavai/
n11http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61388971%3A_____%2F06%3A00040375%21RIV07-AV0-61388971/
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61388971%3A_____%2F06%3A00040375%21RIV07-AV0-61388971
rdf:type
n7:Vysledek skos:Concept
dcterms:description
V této práci jsme pro imunizaci myší použili ACT toxoid, který obsahoval epitop CSP Plasmodium berhei. To vedlo k indukci velkého počtu IFN-gamma-sekretujících CD8+ T buněk, ale nedošlo k vytvoření protektivní imunity. Avšak, pokud byla podána anti CTLA-4 protilátka během boost imunizace, bylo v myších dosaženo ochrany proti letální dávce sporozoitů P. berghei ANKA (ANtwerpKAtango) In the present study, we used for mice immunization recombinant detoxified ACT containing an epitope of Plasmodium berghei CSP. This induced a high number of IFN-gamma-secreting CD8+ T cells, while no protective immunity was achieved. In contrast, when anti-CTLA-4 was administered during boost immunization, complete protection against challenge with P. berghei ANKA (ANtwerpKAtango) sporozoites was induced in a number of mice In the present study, we used for mice immunization recombinant detoxified ACT containing an epitope of Plasmodium berghei CSP. This induced a high number of IFN-gamma-secreting CD8+ T cells, while no protective immunity was achieved. In contrast, when anti-CTLA-4 was administered during boost immunization, complete protection against challenge with P. berghei ANKA (ANtwerpKAtango) sporozoites was induced in a number of mice
dcterms:title
Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria Imunizace adenylát cyklázovým toxinem Bordetella pertussis nesoucím epitop CSP spolu s blokací CTLA-4 receptoru zajištuje protekci proti malárii působené Plasmodium berghei
skos:prefLabel
Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria Immunization with a Circumsporozoite Epitope Fused to Bordetella pertussis Adenylate Cyclase in Conjunction with Cytotoxic T-Lymphocyte-Associated Antigen 4 Blockade Confers Protection against Plasmodium berghei Liver-Stage Malaria Imunizace adenylát cyklázovým toxinem Bordetella pertussis nesoucím epitop CSP spolu s blokací CTLA-4 receptoru zajištuje protekci proti malárii působené Plasmodium berghei
skos:notation
RIV/61388971:_____/06:00040375!RIV07-AV0-61388971
n3:strany
2277;2285
n3:aktivita
n14:Z n14:P
n3:aktivity
P(IBS5020311), Z(AV0Z50200510)
n3:cisloPeriodika
4
n3:dodaniDat
n17:2007
n3:domaciTvurceVysledku
n8:7308574 n8:1076329 n8:2889528
n3:druhVysledku
n16:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
478865
n3:idVysledku
RIV/61388971:_____/06:00040375
n3:jazykVysledku
n18:eng
n3:klicovaSlova
plasmodium berghei; immunity; malaria
n3:klicoveSlovo
n4:immunity n4:plasmodium%20berghei n4:malaria
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[FEB7B12E1873]
n3:nazevZdroje
Infection and Immunity
n3:obor
n10:EE
n3:pocetDomacichTvurcuVysledku
3
n3:pocetTvurcuVysledku
8
n3:projekt
n15:IBS5020311
n3:rokUplatneniVysledku
n17:2006
n3:svazekPeriodika
74
n3:tvurceVysledku
Šimšová, Marcela Šebo, Peter Bolte, S. Jacobs, T. Heussler, V. Fleischer, B. Kamanová, Jana Tartz, S.
n3:zamer
n11:AV0Z50200510
s:issn
0019-9567
s:numberOfPages
9